About: Tak Wah Mak     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:WikicatFellowsOfTheRoyalSocietyOfCanada, within Data Space : dbpedia.org associated with source document(s)
QRcode icon
http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FTak_Wah_Mak&graph=http%3A%2F%2Fdbpedia.org&graph=http%3A%2F%2Fdbpedia.org

Tak Wah Mak, OC OOnt FRS FRSC (simplified Chinese: 麦德华; traditional Chinese: 麥德華; pinyin: Mài Déhuá; born October 4, 1946, in China) is a Canadian medical researcher, geneticist, oncologist, and biochemist. He first became widely known for his discovery of the T-cell receptor in 1983 and pioneering work in the genetics of immunology. In 1995, Mak published a landmark paper on the discovery of the function of the immune checkpoint protein CTLA-4, thus opening the path for immunotherapy/checkpoint inhibitors as a means of cancer treatment. Mak is also the founder of Agios Pharmaceuticals, whose lead compound, IDHIFA®, was approved by the FDA for acute myeloid leukemia in August 2017, becoming the first drug specifically targeting cancer metabolism to be used for cancer treatment. He has work

AttributesValues
rdf:type
rdfs:label
  • تاك واه ماك (ar)
  • Tak Wah Mak (de)
  • Tak Wah Mak (eu)
  • Tak Wah Mak (en)
  • Tak Wah Mak (pt)
  • 麦德华 (zh)
rdfs:comment
  • تاك واه ماك (بالإنجليزية: Tak Wah Mak، وبالصينية: 麥德華) ـ (ولد في الصين في 4 أكتوبر 1946) هو باحث طبي وعالم وراثة وأورام وكيمياء حيوية كندي، صيني المولد. اشتهر على نطاق واسع لاكتشافه مستقبل خلية تي، ولأبحاثه الرائدة في مجال علم الوراثة المناعي. شملت اهتماماته البحثية أيضًا الكيمياء الحيوية وعلم المناعة وعلم وراثة السرطان. حصل ماك على جائزة الملك فيصل العالمية في الطب سنة 1416 هـ/1995 م، كما حصل على وسام أونتاريو سنة 2007. (ar)
  • Tak Wah Mak (* 4. Oktober 1946 in Guangzhou, China) ist ein kanadischer Immunbiologe, Krebsforscher und Professor an der University of Toronto. Er ist chinesischer Herkunft. (de)
  • Tak Wah Mak (Cantão, China, 4 de outubro de 1946) é um imunologista e pesquisador do câncer canadense de origem chinesa. É professor da Universidade de Toronto. (pt)
  • 麦德华(英語:Tak Wah Mak,1946年10月4日-),免疫学家、生物化学专家以及癌症基因专家,2000年加拿大「Order of Canada」勋章获得者。 (zh)
  • Tak Wah Mak, (txinera tradizionalez: 麥德華; Txina, 1946ko urriaren 4a) kanadar biologoa da. Hamabi urte zituela Hong Kongera aldatu zen familiarekin batera; aita negozio gizona zuen eta familia nahiko aberatsa zen. eta Albertako Unibertsitatean egin zituen ikasketak; Albertan eskuratu zuen doktoregoa. 1970eko hamarraldian ikerketak egiten hasi zen Ontarioko Minbiziaren Institutuan, eta gaur egun Torontoko Unibertsitateko Immunologia katedraduna da, eta Torontoko Amgen Ikerketa Institutuko zuzendaria, besteak beste. Immunologiaren eta biologia molekularraren alorretan egin ditu lan aipagarrienak. Azken hamarraldian, eta ingeniaritza genetikoko teknikak erabiliz, Tak Makek eta bere ikerketa taldeak aurrerapen handiak egin dituzte gizakiaren immunologia sistemaren egitura eta funtzioak argitze (eu)
  • Tak Wah Mak, OC OOnt FRS FRSC (simplified Chinese: 麦德华; traditional Chinese: 麥德華; pinyin: Mài Déhuá; born October 4, 1946, in China) is a Canadian medical researcher, geneticist, oncologist, and biochemist. He first became widely known for his discovery of the T-cell receptor in 1983 and pioneering work in the genetics of immunology. In 1995, Mak published a landmark paper on the discovery of the function of the immune checkpoint protein CTLA-4, thus opening the path for immunotherapy/checkpoint inhibitors as a means of cancer treatment. Mak is also the founder of Agios Pharmaceuticals, whose lead compound, IDHIFA®, was approved by the FDA for acute myeloid leukemia in August 2017, becoming the first drug specifically targeting cancer metabolism to be used for cancer treatment. He has work (en)
foaf:name
  • Tak Wah Mak (en)
name
  • Tak Wah Mak (en)
birth place
birth place
  • China (en)
birth date
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (61 GB total memory, 42 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software